BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20027199)

  • 1. Myc and a Cdk2 senescence switch.
    van Riggelen J; Felsher DW
    Nat Cell Biol; 2010 Jan; 12(1):7-9. PubMed ID: 20027199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cdk2 suppresses cellular senescence induced by the c-myc oncogene.
    Campaner S; Doni M; Hydbring P; Verrecchia A; Bianchi L; Sardella D; Schleker T; Perna D; Tronnersjö S; Murga M; Fernandez-Capetillo O; Barbacid M; Larsson LG; Amati B
    Nat Cell Biol; 2010 Jan; 12(1):54-9; sup pp 1-14. PubMed ID: 20010815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdk2: a key regulator of the senescence control function of Myc.
    Hydbring P; Larsson LG
    Aging (Albany NY); 2010 Apr; 2(4):244-50. PubMed ID: 20445224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation by Cdk2 is required for Myc to repress Ras-induced senescence in cotransformation.
    Hydbring P; Bahram F; Su Y; Tronnersjö S; Högstrand K; von der Lehr N; Sharifi HR; Lilischkis R; Hein N; Wu S; Vervoorts J; Henriksson M; Grandien A; Lüscher B; Larsson LG
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):58-63. PubMed ID: 19966300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myc, Cdk2 and cellular senescence: Old players, new game.
    Campaner S; Doni M; Verrecchia A; Fagà G; Bianchi L; Amati B
    Cell Cycle; 2010 Sep; 9(18):3655-61. PubMed ID: 20818171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tipping the balance: Cdk2 enables Myc to suppress senescence.
    Hydbring P; Larsson LG
    Cancer Res; 2010 Sep; 70(17):6687-91. PubMed ID: 20713526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes.
    Müller D; Bouchard C; Rudolph B; Steiner P; Stuckmann I; Saffrich R; Ansorge W; Huttner W; Eilers M
    Oncogene; 1997 Nov; 15(21):2561-76. PubMed ID: 9399644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin-Dependent Kinase 2 in Cellular Senescence and Cancer. A Structural and Functional Review.
    Volkart PA; Bitencourt-Ferreira G; Souto AA; de Azevedo WF
    Curr Drug Targets; 2019; 20(7):716-726. PubMed ID: 30516105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CDK2 differentially controls normal cell senescence and cancer cell proliferation upon exposure to reactive oxygen species.
    Hwang CY; Lee SM; Park SS; Kwon KS
    Biochem Biophys Res Commun; 2012 Aug; 425(1):94-9. PubMed ID: 22819841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular senescence is an important mechanism of tumor regression upon c-Myc inactivation.
    Wu CH; van Riggelen J; Yetil A; Fan AC; Bachireddy P; Felsher DW
    Proc Natl Acad Sci U S A; 2007 Aug; 104(32):13028-33. PubMed ID: 17664422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional link between Myc and the Werner gene in tumorigenesis.
    Grandori C; Robinson KL; Galloway DA; Swisshelm K
    Cell Cycle; 2004 Jan; 3(1):22-5. PubMed ID: 14657658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myc activation of cyclin E/Cdk2 kinase involves induction of cyclin E gene transcription and inhibition of p27(Kip1) binding to newly formed complexes.
    Pérez-Roger I; Solomon DL; Sewing A; Land H
    Oncogene; 1997 May; 14(20):2373-81. PubMed ID: 9188852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational experiments reveal the efficacy of targeting CDK2 and CKIs for significantly lowering cellular senescence bar for potential cancer treatment.
    Ling H; Samarasinghe S; Kulasiri D
    Biosystems; 2013 Feb; 111(2):71-82. PubMed ID: 23254306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens.
    Carroll JS; Swarbrick A; Musgrove EA; Sutherland RL
    Cancer Res; 2002 Jun; 62(11):3126-31. PubMed ID: 12036924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC can enforce cell cycle transit from G1 to S and G2 to S, but not mitotic cellular division, independent of p27-mediated inihibition of cyclin E/CDK2.
    Deb-Basu D; Karlsson A; Li Q; Dang CV; Felsher DW
    Cell Cycle; 2006 Jun; 5(12):1348-55. PubMed ID: 16760657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methods to Study Myc-Regulated Cellular Senescence: An Update.
    Zhang F; Bazzar W; Alzrigat M; Larsson LG
    Methods Mol Biol; 2021; 2318():241-254. PubMed ID: 34019294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis.
    Macias E; Kim Y; Miliani de Marval PL; Klein-Szanto A; Rodriguez-Puebla ML
    Cancer Res; 2007 Oct; 67(20):9713-20. PubMed ID: 17942901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDK2 is required by MYC to induce apoptosis.
    Deb-Basu D; Aleem E; Kaldis P; Felsher DW
    Cell Cycle; 2006 Jun; 5(12):1342-7. PubMed ID: 16760655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Down-regulation and decreased activity of cyclin-dependent kinase 2 in H2O2-induced premature senescence.
    Frippiat C; Remacle J; Toussaint O
    Int J Biochem Cell Biol; 2003 Feb; 35(2):246-54. PubMed ID: 12479875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adhesion-regulated G1 cell cycle arrest in epithelial cells requires the downregulation of c-Myc.
    Benaud CM; Dickson RB
    Oncogene; 2001 Jul; 20(33):4554-67. PubMed ID: 11494151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.